1. Home
  2. DCO vs REPL Comparison

DCO vs REPL Comparison

Compare DCO & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCO
  • REPL
  • Stock Information
  • Founded
  • DCO 1849
  • REPL 2015
  • Country
  • DCO United States
  • REPL United States
  • Employees
  • DCO N/A
  • REPL N/A
  • Industry
  • DCO Military/Government/Technical
  • REPL Biotechnology: Pharmaceutical Preparations
  • Sector
  • DCO Industrials
  • REPL Health Care
  • Exchange
  • DCO Nasdaq
  • REPL Nasdaq
  • Market Cap
  • DCO 919.0M
  • REPL 965.8M
  • IPO Year
  • DCO N/A
  • REPL 2018
  • Fundamental
  • Price
  • DCO $61.19
  • REPL $11.50
  • Analyst Decision
  • DCO Strong Buy
  • REPL Strong Buy
  • Analyst Count
  • DCO 4
  • REPL 6
  • Target Price
  • DCO $73.00
  • REPL $17.50
  • AVG Volume (30 Days)
  • DCO 158.3K
  • REPL 1.1M
  • Earning Date
  • DCO 02-13-2025
  • REPL 02-06-2025
  • Dividend Yield
  • DCO N/A
  • REPL N/A
  • EPS Growth
  • DCO 41.24
  • REPL N/A
  • EPS
  • DCO 2.00
  • REPL N/A
  • Revenue
  • DCO $781,490,000.00
  • REPL N/A
  • Revenue This Year
  • DCO $5.17
  • REPL N/A
  • Revenue Next Year
  • DCO $6.18
  • REPL $300.41
  • P/E Ratio
  • DCO $31.78
  • REPL N/A
  • Revenue Growth
  • DCO 3.78
  • REPL N/A
  • 52 Week Low
  • DCO $47.53
  • REPL $4.92
  • 52 Week High
  • DCO $70.50
  • REPL $17.00
  • Technical
  • Relative Strength Index (RSI)
  • DCO 40.49
  • REPL 39.75
  • Support Level
  • DCO $62.52
  • REPL $12.00
  • Resistance Level
  • DCO $65.30
  • REPL $12.79
  • Average True Range (ATR)
  • DCO 2.55
  • REPL 0.59
  • MACD
  • DCO -0.36
  • REPL -0.23
  • Stochastic Oscillator
  • DCO 5.62
  • REPL 0.47

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used primarily in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in worldwide technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.

Share on Social Networks: